The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs

被引:48
作者
Wang, Yen-Jen [1 ]
Larsson, Mikael [2 ]
Huang, Wei-Ting [1 ]
Chiou, Shih-Hwa [3 ,4 ]
Nicholls, Stephen J. [5 ]
Chao, Jui-I [6 ]
Liu, Dean-Mo [1 ]
机构
[1] Natl Chiao Tung Univ, BioICT Consortium, Dept Mat Sci & Engn, Nanobioengn Lab, Hsinchu 301, Taiwan
[2] Univ S Australia, Future Ind Inst, Mawson Lakes Campus, Mawson Lakes, SA 5095, Australia
[3] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan
[4] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan
[5] Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia
[6] Natl Chiao Tung Univ, BioICT Consortium, Dept & Inst Biol Sci & Technol, Hsinchu 300, Taiwan
关键词
Cardiovascular diseases; Drug delivery; Nanoparticles; Nanostructured; Polymers; Theranostic; DRUG-ELUTING STENTS; SMOOTH-MUSCLE-CELLS; LOW-DENSITY-LIPOPROTEIN; BLOOD-BRAIN-BARRIER; BARE METAL STENTS; IN-VIVO; LOCAL-DELIVERY; BIODEGRADABLE NANOPARTICLES; GENE DELIVERY; NEOINTIMAL HYPERPLASIA;
D O I
10.1016/j.progpolymsci.2016.01.002
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
This review summarizes important advances in polymer-based nanotechnologies for the treatment and diagnosis of cardiovascular diseases, focusing on nanoparticles and nanostructured materials/devices. The current state of the art and design parameters are discussed with the aim of providing a source of information that can aid in the development of new treatments by bridging between materials development, preclinical, and clinical trials. This is highly relevant as cardiovascular diseases remain a leading cause of death worldwide and as current treatments burden the healthcare systems with great costs. Different strategies, from targeting theranostic nanocarriers, to dual-drug depot systems, injectable cell scaffolds, and LDL acceptors are treated. The review ends with a concluding outlook on the ossibilities and challenges presented to polymer-based nanotechnologies in cardiovascular disease therapy. (c) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:153 / 178
页数:26
相关论文
共 242 条
  • [41] Drug-eluting stent update 2007 part I: a survey of current and future generation drug-eluting stents: meaningful advances or more of the same?
    Daemen, Joost
    Serruys, Patrick W.
    [J]. CIRCULATION, 2007, 116 (03) : 316 - 328
  • [42] Dalmoro A, 2015, J BIOMED MAT RES B
  • [43] Characterization of nanoparticle uptake by endothelial cells
    Davda, J
    Labhasetwar, V
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 233 (1-2) : 51 - 59
  • [44] Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents
    Denardo, Scott J.
    Carpinone, Paul L.
    Vock, David M.
    Tcheng, James E.
    Phillips, Harry R., III
    Willenberg, Bradley J.
    Batich, Christopher D.
    Pepine, Carl J.
    [J]. EUROINTERVENTION, 2013, 9 (03) : 389 - 397
  • [45] Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion
    Denardo, Scott J.
    Carpinone, Paul L.
    Vock, David M.
    Batich, Christopher D.
    Pepine, Carl J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (20): : 2148 - 2150
  • [46] Emerging applications of polymersomes in delivery: From molecular dynamics to shrinkage of tumors
    Discher, Dennis E.
    Ortiz, Vanessa
    Srinivas, Goundla
    Klein, Michael L.
    Kim, Younghoon
    Christian, David
    Cai, Shenshen
    Photos, Peter
    Ahmed, Fariyal
    [J]. PROGRESS IN POLYMER SCIENCE, 2007, 32 (8-9) : 838 - 857
  • [47] Needle-shaped polymeric particles induce transient disruption of cell membranes
    Doshi, Nishit
    Mitragotri, Samir
    [J]. JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2010, 7 : S403 - S410
  • [48] A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action
    Dowling, Matthew B.
    Kumar, Rakesh
    Keibler, Mark A.
    Hess, John R.
    Bochicchio, Grant V.
    Raghavan, Srinivasa R.
    [J]. BIOMATERIALS, 2011, 32 (13) : 3351 - 3357
  • [49] EFFECT OF CONTROLLED ADVENTITIAL HEPARIN DELIVERY ON SMOOTH-MUSCLE CELL-PROLIFERATION FOLLOWING ENDOTHELIAL INJURY
    EDELMAN, ER
    ADAMS, DH
    KARNOVSKY, MJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) : 3773 - 3777
  • [50] Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
    Ernsting, Mark J.
    Murakami, Mami
    Roy, Aniruddha
    Li, Shyh-Dar
    [J]. JOURNAL OF CONTROLLED RELEASE, 2013, 172 (03) : 782 - 794